Health1 min read

Pill that mimics Viagra can slow Alzheimer’s progression, study suggests

By · Via The Guardian Science · Published by Everything Blog

In short

The stage three trial spanned 13 countries to evaluate the daily tablet, which works by relaxing blood vessels to increase blood flow to the brain. In a cohort of 604 participants who were not receiving other treatments, the therapy notably slowed disease progression with mostly mild to moderate side effects. However, the trial failed to demonstrate statistically significant benefits among patients who were concurrently taking other Alzheimer’s medications.

Key points

  • Targeting cerebral blood flow rather than amyloid proteins represents a promising new app…: Targeting cerebral blood flow rather than amyloid proteins represents a promising new approach for dementia treatment.
  • Experts emphasize that AR1001 requires further clinical trials and regulatory scrutiny be…: Experts emphasize that AR1001 requires further clinical trials and regulatory scrutiny before it can be prescribed.
  • Medical professionals warn that individuals should not attempt to treat Alzheimer’s disea…: Medical professionals warn that individuals should not attempt to treat Alzheimer’s disease by taking Viagra.

Sources checked by our analysis pipeline: 1

A pill that mimics Viagra by relaxing blood vessels and increasing blood flow to the brain can slow cognitive decline in people with Alzheimer’s disease by almost a third, a global study suggests.

Alzheimer’s is the most common form of dementia, a condition that is forecast to affect 153 million people worldwide by 2050. There is currently no cure.

In a stage three trial spanning 13 countries, including the UK, researchers found the tablet AR1001 slowed decline by 31% in patients with early Alzheimer’s disease not receiving any other treatment.

Experts not involved with the study urged caution but said the results were “exciting” and “very promising” and could signal the arrival of a “totally new treatment” for Alzheimer’s.

The findings were presented at the Clinical Trials on Alzheimer’s Disease conference in Boston.

AR1001 is a phosphodiesterase-5 inhibitor and from the same family of medicines as Viagra, which is used to treat erectile dysfunction.

The South Korean company AriBio, which makes AR1001, said the drug slowed decline in 604 people taking no other drugs for Alzheimer’s. In a wider group…

Health